Cardiac Myeloid Sarcoma: Review of
Literature
Published: March 1, 2017 | DOI: https://doi.org/10.7860/JCDR/2017/23241.9499
Archana Gautam, Ghazal Kooshk Jalali, Kamal Kant Sahu, Prateek Deo, Sikander Ailawadhi
1. Junior Resident, Department of Internal Medicine, UCMS, New Delhi, India.
2. Senior Resident, Department of Internal Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
3. Senior Resident, Department of Internal Medicine, PGIMER, Chandigarh, India.
4. Junior Resident, Department of Internal Medicine, PGIMER, Chandigarh, India.
5. Senior Associate Consultant, Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida.
Correspondence
Dr. Kamal Kant Sahu,
Senior Resident, Department of Internal Medicine, Nehru Hospital, PGIMER, Sector 12, Pin-160012, Chandigarh, India.
E-mail: everlastingkamal@yahoo.com
Granulocytic Sarcomas (GS) also called as Myeloid Sarcomas (MS) or chloromas are the representatives of extramedullary infiltrates of immature myeloid cells including myeloblasts, promyelocytes and myelocytes. Primary cardiac malignancies per se are rare and infiltration of cardiac muscles by secondary malignant cells is also an uncommon finding. Out of these cardiac tumors, contribution of Cardiac Myeloid Sarcoma (CMS) is even more smaller thereby limiting our knowledge about this rare entity. Because of its very lower incidence, an exact guideline for diagnosis and management is still missing and usually haematologists around the world are treating CMS based on their clinical acumen. Aim of this review is to briefly discuss the presenting clinical feature, differential diagnosis, diagnostic workup and management based on published articles related to CMS till date.
[
FULL TEXT ] | [ PDF]